Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Modi's party set to gain big in Indian state elections
Evacuations planned as suspected hantavirus outbreak traps 150 on ship off Cape Verde
Iran warns US Navy to stay clear of Hormuz after US offers to help stranded ships
Shooting at lake near Oklahoma City injures 10, more feared
United jet hits truck and light pole on approach to Newark airport
